NutriBand (NTRB) Change in Inventory (2016 - 2026)
NutriBand (NTRB) posted Change in Inventory of $3507.0 for Q2 2026, up 119.47% sequentially from -$18011.0 in Q1 2026, and up 6.82% YoY from $3283.0 in Q2 2025.
NutriBand (NTRB) Change in Inventory (2016 - 2026) Analysis & Trends
NutriBand has reported Change in Inventory for 9 years, with the latest figure at $3507.0 in Q2 2026.
- Quarterly Change in Inventory rose 6.82% year-over-year to $3507.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$93830.0 (down 307.11% YoY) and the FY2026 annual result came in at -$94054.0, down 316.53% from the prior year.
- Change in Inventory improved to $3507.0 in Q2 2026 per NTRB's latest filing, from -$18011.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $53840.0 in Q3 2024 and troughed at -$77293.0 in Q3 2025.
- A 5-year average of -$191.28 and a median of $2349.0 in 2024 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2023 and 2025: Change in Inventory plunged 1062.53% in 2023, then jumped 824.69% in 2025.
- Over 5 years, Change in Inventory stood at $22493.0 in 2022, then declined by 21.22% to $17720.0 in 2023, then sank by 413.55% to -$55561.0 in 2024, then jumped by 96.34% to -$2033.0 in 2025, then surged by 272.5% to $3507.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $3507.0, -$18011.0, and -$2033.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | - |
| 10 | NutriBand | 48.72 Mn | 44.71 Mn | 196,801.00 | 3,507.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 3,507.00 |
| Apr 30, 2026 | 3,507.00 |
| Jan 31, 2026 | -18,011.00 |
| Jan 31, 2026 | -18,011.00 |
| Oct 31, 2025 | -2,033.00 |
| Oct 31, 2025 | -2,033.00 |
| Jul 31, 2025 | -77,293.00 |
| Jul 31, 2025 | -77,293.00 |
| Apr 30, 2025 | 3,283.00 |
| Apr 30, 2025 | 3,283.00 |
| Jan 31, 2025 | 43,742.00 |
| Jan 31, 2025 | 43,742.00 |
| Oct 31, 2024 | -55,561.00 |
| Oct 31, 2024 | -55,561.00 |
| Jul 31, 2024 | 53,840.00 |
| Jul 31, 2024 | 53,840.00 |
| Apr 30, 2024 | 1,415.00 |
| Apr 30, 2024 | 1,415.00 |
| Jan 31, 2024 | -6,036.00 |
| Jan 31, 2024 | -6,036.00 |